With New Sleeping Pill, New Acceptability?
Article Abstract:
A new sleeping pill from Sepracor Inc. has just be licensed by the Food and Drug Administration. Lunesta, known generically as eszopiclone, has been shown to be safe and remain effective for at least six months of continued usage.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Data Theft: How to Fix The Mess
Article Abstract:
Senator William Proxmire's bills that held the credit card industry accountable for fraud in the 1970s provide a good example of how to prevent fraud and identity theft and simultaneously increase industry profitability.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
A C.E.O. Who Carries A Big Stick
Article Abstract:
Cybertronics, a medical device maker, has just introduced in implantable device to treat depression. Chief executive Robert P. Cummins' reputation as a bully may be affecting the stock price of the company.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Reconciling reality. Jeff Kennett: in his own words by his own rules. The battles of Beevor
- Abstracts: The New Marketing Chief Is Likely to Steer a Less-Cola Future. All Is Not Sweet at the Home Base of Coca-Cola
- Abstracts: Stelco talks hit an impasse. Stelco investors told their stock now worthless. Stelco, union reach truce over plans
- Abstracts: Chevron/Unocal deal seen fuelling oil patch M&A activity. Oil price seen sparkling alternatives
- Abstracts: The housing market: Is the boom over? Home sales on pace to shatter records. The new mantra; condo, condo, condo